Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Risk factors for Coronavirus disease-associated mucormycosis
Umang Arora, Megha Priyadarshi, Varidh Katiyar, et al.
Journal of Infection (2021) Vol. 84, Iss. 3, pp. 383-390
Open Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Multicenter Case–Control Study of COVID-19–Associated Mucormycosis Outbreak, India
Valliappan Muthu, Ritesh Agarwal, Shivaprakash M. Rudramurthy, et al.
Emerging infectious diseases (2023) Vol. 29, Iss. 1, pp. 8-19
Open Access | Times Cited: 47
Global Cutaneous Mucormycosis: A Systematic Review
Anna Skiada, Maria Drogari‐Apiranthitou, Ioannis Pavleas, et al.
Journal of Fungi (2022) Vol. 8, Iss. 2, pp. 194-194
Open Access | Times Cited: 49
Burden of Serious Fungal Infections in India
Animesh Ray, Adarsh Aayilliath K, Sayantan Banerjee, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 12
Open Access | Times Cited: 42
Pathogenesis and Pathology of COVID-Associated Mucormycosis: What Is New and Why
Bishan Radotra, Sundaram Challa
Current Fungal Infection Reports (2022) Vol. 16, Iss. 4, pp. 206-220
Open Access | Times Cited: 31
COVID-19-associated mucormycosis in India: Why such an outbreak?
Grégoire Pasquier
Journal de Mycologie Médicale (2023) Vol. 33, Iss. 3, pp. 101393-101393
Open Access | Times Cited: 19
Multimodal analysis of the COVID‐19‐associated mucormycosis outbreak in Delhi, India indicates the convergence of clinical and environmental risk factors
Anuradha Chowdhary, Nitesh Gupta, Sebastian Wurster, et al.
Mycoses (2023) Vol. 66, Iss. 6, pp. 515-526
Open Access | Times Cited: 17
Mucormycosis in the COVID-19 Environment: A Multifaceted Complication
Rohit Sharma, Praveen Kumar, Abdur Rauf, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 26
COVID-19-Associated Mucormycosis: A Matter of Concern Amid the SARS-CoV-2 Pandemic
Pankaj Chandley, Priyanka Subba, Soma Rohatgi
Vaccines (2022) Vol. 10, Iss. 8, pp. 1266-1266
Open Access | Times Cited: 23
The battle against fungi: lessons in antifungal stewardship from COVID 19 times
Souha S. Kanj, Sara F. Haddad, Jacques F. Meis, et al.
International Journal of Antimicrobial Agents (2023) Vol. 62, Iss. 1, pp. 106846-106846
Open Access | Times Cited: 16
Epidemiology of COVID-19–Associated Mucormycosis
Khadija Tayabali, Hussein Pothiwalla, Shivakumar Narayanan
Current Fungal Infection Reports (2023) Vol. 17, Iss. 2, pp. 156-175
Open Access | Times Cited: 14
COVID-19-Associated Pulmonary Mucormycosis
Vidya Krishna, N.K. Bansal, Jaymin B. Morjaria, et al.
Journal of Fungi (2022) Vol. 8, Iss. 7, pp. 711-711
Open Access | Times Cited: 20
RETRACTED: Physio-metabolic and clinical consequences of wearing face masks—Systematic review with meta-analysis and comprehensive evaluation
Kai Kisielinski, Oliver Hirsch, Susanne Wagner, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 12
Clinical Features and Treatment Progress of Invasive Mucormycosis in Patients with Hematological Malignancies
Nuobing Yang, Lining Zhang, Sizhou Feng
Journal of Fungi (2023) Vol. 9, Iss. 5, pp. 592-592
Open Access | Times Cited: 10
Evaluating Risk Factors for COVID-19-associated Mucormycosis: Insights from a Case Series
Shefali Gautam, Shashank Kumar, Shreya Mahesh, et al.
(2025) Vol. 1, Iss. 2, pp. 29-31
Closed Access
Recommendations and guidelines for the diagnosis and management of Coronavirus Disease-19 (COVID-19) associated bacterial and fungal infections in Taiwan
Huan-Yi Wu, Peng-Hao Chang, Yu‐Shan Huang, et al.
Journal of Microbiology Immunology and Infection (2022) Vol. 56, Iss. 2, pp. 207-235
Open Access | Times Cited: 15
Could cattle dung burning have contributed to the epidemic of COVID‐19‐associated mucormycosis in India? Results of an experimental aero‐mycological study
Soundappan Kathirvel, Valliappan Muthu, Shivaprakash M. Rudramurthy, et al.
Mycoses (2022) Vol. 65, Iss. 11, pp. 1024-1029
Open Access | Times Cited: 11
A case control investigation of COVID-19 associated mucormycosis in India
Tanu Anand, Aparna Mukherjee, Aanchal Satija, et al.
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 10
Clinical Phenotypes of COVID-19 Associated Mucormycosis (CAM): A Comprehensive Review
Maria Panagiota Almyroudi, Karolina Akinosoglou, Jordi Rello, et al.
Diagnostics (2022) Vol. 12, Iss. 12, pp. 3092-3092
Open Access | Times Cited: 9
The effect of zinc on the outcome of patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials
Jheng‐Yan Wu, Tinghui Liu, Po‐Yu Huang, et al.
Journal of Infection (2023) Vol. 86, Iss. 5, pp. e142-e143
Open Access | Times Cited: 4
COVID-19, mucormycosis, and the cow: Damned lies!
Valliappan Muthu, Ritesh Agarwal, Arunaloke Chakrabarti
Indian Journal of Medical Microbiology (2023) Vol. 44, pp. 100382-100382
Open Access | Times Cited: 4
Metagenomic insights into fungal community composition of the nasopharyngeal region of COVID‐19 associated mucormycosis patients from India
Bharathi Arunan, Daizee Talukdar, Satish Swain, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 4
Closed Access | Times Cited: 1
Risk Factors of COVID-19 associated mucormycosis in Iranian patients: a multicenter study
Bahram Eshraghi, Behzad Khademi, Majid Mirmohammadkhani, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Epidemiology of Mucormycosis in Greece; Results from a Nationwide Prospective Survey and Published Case Reports
Maria Drogari‐Apiranthitou, Anna Skiada, Ioannis G. Panayiotides, et al.
Journal of Fungi (2023) Vol. 9, Iss. 4, pp. 425-425
Open Access | Times Cited: 3
Post-COVID-19 rhino-orbito-cerebral mucormycosis—A clinico-mycological study from North India
Juhi Taneja, Kuhu Chatterjee, Jaseetha Sasidharan, et al.
Medical Mycology (2023) Vol. 61, Iss. 7
Closed Access | Times Cited: 3
Risk Factors, Clinical Manifestations, and Outcomes of COVID-19-Associated Mucormycosis and Other Opportunistic Fungal Infections
Dinesh Kumar, Faiz Ahmad, Anil Kumar, et al.
Cureus (2023)
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top